Summary Background: Due to ever increasing referral rates, we have had to move the nasal CPAP induction program for patients with obstructive sleep apnoea (OSA) out of the sleep laboratories and into an outpatient setting. We report the effects this has had on patient outcomes.
Introduction
Rising numbers of referrals to the Sleep Unit forced us to consider ways to increase the availability of diagnostic sleep laboratory spaces or accept ever increasing waiting times. Various authors have reported on home CPAP titrations, 1 and recent evidence suggests that an overnight titration might not be necessary to achieve adequate control of obstructive sleep apnoea (OSA). 2 We therefore designed an outpatient-based CPAP induction programme, using algorithm-derived CPAP pressures for subsequent home use. A previous companion paper describes the rationale behind the use of an algorithm to set the CPAP pressure. This paper describes the long-term outcomes of changing the way we establish patients with OSA on CPAP, from our previous sleep laboratory-based approach, to this new outpatient-based system.
Methods
The presence of OSA was established by a one-night sleep study, recording body movement and heart rate as markers of sleep disturbance, with arterial oxygen saturation measurements (SaO 2 ) and snoring as markers of respiratory impairment, and measurements of pulse transit time to differentiate obstructive from central apnoeas 3 (Visi-Lab monitoring system, Stowood Scientific Systems, Oxford, UK). 4 In addition, a video recording of the whole night is available to confirm that abnormalities seen on the tracings are due to OSA. The severity of OSA was quantified from the number of 44% falls in SaO 2 /h of study and shown in Table 1 for the patients in this study. This predicts the severity of OSA symptoms, and its response to treatment, at least as well as any other index. 4 Patients with OSA in our sleep unit are diary-booked for CPAP, following a sleep study and medical outpatient review, where the appropriateness of this therapy is established. They are given written information at this time, as well as a prescription for nasal steroids and anticholinergics to be used for five nights prior to admission. The waiting time varies between 2 and 4 months. Our previous system for establishing patients on nasal CPAP required patients to attend the ward at 7.30 p.m. They were met by one of the sleep nurses and introduced individually to nasal CPAP, which included a video covering most aspects of CPAP usage, including interviews with patients describing their experiences with this therapy. They were then fitted with an appropriate mask and given the opportunity to get used to the system, and ask any questions. The patients were then left to connect to an automatic titrating CPAP machine (Sunrise Horizon LT) later on in the evening at their chosen bedtime. This autotitrating CPAP machine has been shown to establish similar pressures for subsequent usage compared to manual titration. 5 During the overnight titration, the ordinary ward night nurses responded to emergency calls, but were not otherwise involved. The following morning, the sleep nurse and patient reviewed the sleep study together and discussed how the patient had got on overnight. In addition, the sleep nurse established the required CPAP pressure by reviewing the Visi-Lab tracings (which included the CPAP pressure) and prepared a fixed pressure machine set at this pressure, for the patient to take home. This pressure was usually the 95th centile, having allowed for any areas of artefact, such as 'mask off' periods. When the patient was confident with the equipment, he took it home, and was given a telephone number to call if there were any problems. This telephone helpline is in operation 9 a.m.-5 p.m. with an answerphone for out of hours messages, which are responded to the next working day. The patients were then seen 1 month later in the nurse-led follow up clinic to review progress. If all was well they were booked for an annual follow up clinic with instructions to contact the helpline if required. Simple problems are solved by telephone if possible, with the patients returning to clinic earlier if required.
ARTICLE IN PRESS
The new system required patients to arrive on the ward at 1.30 p.m. where they are met by one or two specialist nurses. They then receive a similar This figure includes any reason, e.g. going for surgery, trying a dental device, other life events and illnesses. In addition, anyone in whom we were unable to verify compliance we have assumed non-usage.
induction programme to the old system, but in a group of three or four, although the actual mask fitting is done individually. Again, once the nurse and patient are confident with the apparatus, he goes home with a fixed pressure machine set at a pressure determined from an algorithm, based on neck circumference and OSA severity (as measured from the 44% SaO 2 dips/h during the diagnostic sleep study). This is described in the companion paper, although during the course of this study we added 1 cmH 2 O to the algorithm-derived pressure, as we were anxious not to undertreat. Again, the patients have access to the telephone helpline and are then seen in the follow up clinic. All care thereafter is identical to the previous system with extra outpatient appointments only if problems cannot be solved by telephone. The last 75 patients undergoing the old system of overnight hospital titration were followed at 1 and 11 months (group 1), and compared with the first 75 patients in the new system (group 2). This allowed us to answer the simple question, 'did changing from our old system, to a simpler and less expensive approach, reduce the success rate of getting patients onto nasal CPAP, as judged by take up rates, Epworth Sleep Scores (ESS), and numbers of clinic appointments during the first 11 months?' The two groups were compared using unpaired Ttests and Chi 2 as appropriate.
Results Table 1 shows the baseline data for the two groups, showing no significant differences in age, initial sleepiness (ESS) or OSA severity (44% SaO 2 dips/h). The algorithm-derived CPAP pressure was higher than the titration pressures by about the extra 1 cmH 2 O we had arbitrarily added to try to avoid undertreating. There are no significant differences in our chosen endpoints at either 1 or 11 months. Included in the figures for 'giving up' are patients who stopped using CPAP for any reason, including going for surgery, trying a dental device, and other life events (such as illness or hospital admissions). In addition, for anyone in whom we were unable to verify compliance (e.g. they failed to come to outpatient appointments or respond to telephone calls) we also assumed non-usage.
Discussion
This simple study has shown that changing to an outpatient-based system to initiate nCPAP therapy for OSA has not reduced take up rates or compliance, nor lessened the beneficial effects on the ESS.
There is a problem with this study as we were not able to run the two systems concurrently and had to change over on a particular date. Although we believe we were comparing similar populations, it was not a randomised parallel study and therefore there may have been differences between the groups. Although our criteria for suggesting a trial of nasal CPAP are broadly an ESSX10, and more than 1044% SaO 2 dips/h, flexibility is allowed in individual cases. However, the ESS and 44% dips/h are very similar in the two groups. The initial ESS figures, and those at 1 and 11 months, are also very similar to those obtained in a randomised controlled trial of nasal CPAP we performed 2 years previously, 6, 7 suggesting no substantial drift in prescribing thresholds. The figures for discontinuation rates at 11 months are similar to other published series. 8, 9 In addition, we have only looked at ESS as a marker of successful therapy. Nasal CPAP has been shown to lower blood pressure in patients with OSA 10,11 and we do not know if the falls were the same in the two groups, although there are no reasons to suspect a difference.
Adequacy of CPAP therapy could be ensured by the routine use of autotitrating machines at home for one or more nights, or as a subsequent check after a period on an algorithm-derived pressure. However, we put approximately 10 patients a week on nCPAP and have not been able to purchase enough autoCPAP machines for this clinical load. The machines we do have are used more selectively when there are specific problems such as nonresolution of sleepiness, or discomfort with mask and poor compliance figures.
We were initially concerned that patients would not like being together for part of the CPAP induction program. However, at an anecdotal level, the reverse appears to be the case. The patients give each other moral support and benefit from meeting again at the follow up appointment.
Conclusions
In conclusion, our introduction of an outpatient nasal CPAP programme, in response to increasing referrals without commensurate increases in resources, does not appear to have led to a deterioration in our services, as assessed by the outcome measures of ESS, CPAP compliance, discontinuation rates, and the need for outpatient appointments to solve problems. However, a parallel trial, perhaps with measurements of 24 h blood pressure as well, is required before the equivalence of the two approaches can be proven robustly.
